Fiscal 2016 Performance Data
Information on Funding Provided to Medical Institutions*
|Research and development||Expenses for trials, reports, and surveillance studies conducted under public regulations (clinical trials for new devices, post-marketing clinical studies, nonconformity and infection case reports, post-marketing surveillance studies, etc.) in addition to those for independent investigations.||Amount (1,000JPY)
|Academic research support||Expenses for scholarships, general and academic conference donations, as well as academic conference co-sponsoring expenses||121,520|
|Manuscript writing fees, etc.||Expenses for lectures, manuscript writing, and the consignment of services, including consulting, to provide information regarding the appropriate use of medical devices and clinical reagents.||43,264|
|Expenses related to information provision||Expenses for lectures, workshops, and seminars to provide healthcare professionals with relevant information regarding appropriate and safe use of medical devices and clinical reagents.||162,654|
|Other expense||Expenses for receptions and social courtesy||37,144|
|Relevant payments or transfer of value||Number||450||443||242|
|Amount||US $186,645||US $190,638||US $137,658|
|Amount||US $194,150||US $76,061||US $209,370|
|Relevant payments or transfer of value||Number||365||226||223|
|Amount||€ 42,856||€ 14,367||€ 29,542|
Contract amounts are not required under the French Sunshine Act.
* This information might be modified after our disclosure according to review by government authorities or medical institutions.